{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:43:14Z","timestamp":1775076194800,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp; Perspec"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clozapine is the only antipsychotic agent with demonstrated efficacy in refractory schizophrenia. However, use of clozapine is hampered by its adverse effects, including potentially fatal agranulocytosis. Recently, we showed an association between neutrophil autofluorescence and clozapine use. In this study, we evaluated the subcellular localization of clozapine\u2010associated fluorescence and tried to elucidate its source. Neutrophils of clozapine users were analyzed with fluorescence microscopy to determine the emission spectrum and localization of the fluorescence signal. Next, these neutrophils were stimulated with different degranulation agents to determine the localization of fluorescence. Lastly, isolated neutrophil lysates of clozapine users were separated by SDS\u2010PAGE and evaluated. Clozapine\u2010associated fluorescence ranged from 420\u00a0nm to 720\u00a0nm, peaking at 500\u2010550\u00a0nm. Fluorescence was localized in a large number of small loci, suggesting granular localization of the signal. Neutrophil degranulation induced by Cytochalasin B\/fMLF reduced fluorescence, whereas platelet\u2010activating factor (PAF)\/fMLF induced degranulation did not, indicating that the fluorescence originates from a secretable substance in azurophilic granules. SDS\u2010PAGE of isolated neutrophil lysates revealed a fluorescent 14kDa band, suggesting that neutrophil fluorescence is likely to be originated from a 14kDa protein\/peptide fragment. We conclude that clozapine\u2010associated fluorescence in neutrophils is originating from a 14kDa soluble protein (fragment) present in azurophilic granules of neutrophils. This protein could be an autofluorescent protein already present in the cell and upregulated by clozapine, or a protein altered by clozapine to express fluorescence. Future studies should further explore the identity of this protein and its potential role in the pathophysiology of clozapine\u2010induced agranulocytosis.<\/jats:p>","DOI":"10.1002\/prp2.627","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T06:25:08Z","timestamp":1598595908000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neutrophil fluorescence in clozapine users is attributable to a 14kDa secretable protein"],"prefix":"10.1002","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-3348","authenticated-orcid":false,"given":"Sera A. J.","family":"de With","sequence":"first","affiliation":[{"name":"Department of Psychiatry University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai H.","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy University Medical Center Utrecht Utrecht The Netherlands"},{"name":"Department of Clinical Pharmacy Meander Medical Center Amersfoort The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen","family":"Maas","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Haematology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"ten Berg","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Haematology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiepke","family":"Cahn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold C.","family":"Koekman","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Haematology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter W.","family":"van Solinge","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Haematology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Tak","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Laboratory of Translational Immunology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"e_1_2_9_3_1","unstructured":"Administration U states F and D. FDA Label Clozapine.1989."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.1.82"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.3.701"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.483"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307153290303"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90206-8"},{"issue":"3","key":"e_1_2_9_9_1","first-page":"3","article-title":"Reducing clozapine\u2010related morbidity and mortality: 5 years of experience with the Clozaril National Registry","volume":"59","author":"Honigfeld G","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_9_10_1","first-page":"1","article-title":"Clozapine\u2010induced agranulocytosis: evidence for an immune\u2010mediated mechanism from a patient\u2010specific in\u2010vitro approach","volume":"316","author":"Regen F","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00006-2"},{"key":"e_1_2_9_12_1","first-page":"1463","article-title":"The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man","volume":"275","author":"Maggs JL","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_13_1","first-page":"1375","article-title":"Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis","volume":"283","author":"Williams DP","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(98)00110-3"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.10.014"},{"key":"e_1_2_9_16_1","first-page":"1476","article-title":"Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells","volume":"275","author":"Liu ZC","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_17_1","first-page":"1","article-title":"Current understanding of the mechanisms of idiosyncratic drug\u2010induced agranulocytosis","volume":"72","author":"Johnston A","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.4128"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-744441"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.08.005"},{"key":"e_1_2_9_21_1","unstructured":"R Core Team.R: A Language and Environment for Statistical Computing.2013."},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781444300017"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4049\/jimmunol.124.2.855","article-title":"The sequential release of granule constitutents from human neutrophils","volume":"124","author":"Bentwood BJ","year":"1980","journal-title":"J Immunol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/817038"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1204697"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.1.207"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00249-003-0361-4"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx500019u"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.5.1504.1504"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1212619"},{"key":"e_1_2_9_31_1","unstructured":"ManWH P\u00e9rez\u2010PitarchA WiltingI et al. Development of a nomogram for the prediction of long\u2010term adherence to clozapine therapy using neutrophil fluorescence. (in submission).2017."},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a007076"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000177668.42640.fe"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.627","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/prp2.627","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T05:06:34Z","timestamp":1693890394000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1002\/prp2.627"],"URL":"https:\/\/doi.org\/10.1002\/prp2.627","archive":["Portico"],"relation":{},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"value":"2052-1707","type":"print"},{"value":"2052-1707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"assertion":[{"value":"2019-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00627"}}